News on Hadassah Medical Organization from BioPortfolio.com http://www.BioPortfolio.com Consolidated Hadassah Medical Organization news from BioPortfolio.com Wed, 10 Feb 2010 13:04:43 GMT en Hand amputation distorts visuospatial perception of the action spacehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028678&HITNO=0&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028678&THISHREF=http://c.moreover.com/click/here.pl%3fz2532816616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028678&HITNO=0&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028678&THISHREF=http://c.moreover.com/click/here.pl%3fz2532816616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Thrombotech to begin Phase I trial of stroke treatment: The safety trial of the peptide will test its possiblehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019183&HITNO=1&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019183&THISHREF=http://c.moreover.com/click/here.pl%3fz2526168051%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019183&HITNO=1&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019183&THISHREF=http://c.moreover.com/click/here.pl%3fz2526168051%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Preoperative Briefing in the Operating Room: Shared Cognition, Teamwork, and Patient Safetyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013897&HITNO=2&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013897&THISHREF=http://c.moreover.com/click/here.pl%3fz2523854096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013897&HITNO=2&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013897&THISHREF=http://c.moreover.com/click/here.pl%3fz2523854096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCHEST: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Triahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953608&HITNO=3&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953608&THISHREF=http://c.moreover.com/click/here.pl%3fz2491830363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953608&HITNO=3&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953608&THISHREF=http://c.moreover.com/click/here.pl%3fz2491830363%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR-USA.net: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMDhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3944258&HITNO=4&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3944258&THISHREF=http://c.moreover.com/click/here.pl%3fz2486435942%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3944258&HITNO=4&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3944258&THISHREF=http://c.moreover.com/click/here.pl%3fz2486435942%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Greater Atlanta Hadassah to Present Forum on Genetic Disease Risks in the Jewish Populationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943994&HITNO=5&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943994&THISHREF=http://c.moreover.com/click/here.pl%3fz2486341086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943994&HITNO=5&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943994&THISHREF=http://c.moreover.com/click/here.pl%3fz2486341086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comThe Weekly: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934628&HITNO=6&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934628&THISHREF=http://c.moreover.com/click/here.pl%3fz2482277787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3934628&HITNO=6&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3934628&THISHREF=http://c.moreover.com/click/here.pl%3fz2482277787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Oramed Pharmaceuticals Announces Completion Of Patient Enrollment For Pivotal Phase 2B Clinical Trials Of ORMDhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933959&HITNO=7&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933959&THISHREF=http://c.moreover.com/click/here.pl%3fz2481993064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933959&HITNO=7&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933959&THISHREF=http://c.moreover.com/click/here.pl%3fz2481993064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMDhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932265&HITNO=8&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932265&THISHREF=http://c.moreover.com/click/here.pl%3fz2480983979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3932265&HITNO=8&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3932265&THISHREF=http://c.moreover.com/click/here.pl%3fz2480983979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMDhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3930404&HITNO=9&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3930404&THISHREF=http://c.moreover.com/click/here.pl%3fz2480029461%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3930404&HITNO=9&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3930404&THISHREF=http://c.moreover.com/click/here.pl%3fz2480029461%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedIndia: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929346&HITNO=10&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929346&THISHREF=http://c.moreover.com/click/here.pl%3fz2479558705%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929346&HITNO=10&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929346&THISHREF=http://c.moreover.com/click/here.pl%3fz2479558705%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Antonio Business Journal: Oramed Pharmaceuticals Announces Completion of Patient Enrollment...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929271&HITNO=11&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929271&THISHREF=http://c.moreover.com/click/here.pl%3fz2479531017%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929271&HITNO=11&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929271&THISHREF=http://c.moreover.com/click/here.pl%3fz2479531017%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMDhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928953&HITNO=12&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928953&THISHREF=http://c.moreover.com/click/here.pl%3fz2479408294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928953&HITNO=12&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928953&THISHREF=http://c.moreover.com/click/here.pl%3fz2479408294%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928929&HITNO=13&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928929&THISHREF=http://c.moreover.com/click/here.pl%3fz2479387519%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928929&HITNO=13&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928929&THISHREF=http://c.moreover.com/click/here.pl%3fz2479387519%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928924&HITNO=14&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928924&THISHREF=http://c.moreover.com/click/here.pl%3fz2479384567%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928924&HITNO=14&MSIZE=38&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hadassah%20Medical%20Organization&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928924&THISHREF=http://c.moreover.com/click/here.pl%3fz2479384567%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: